Faranak Salajegheh

Dr. Faranak Salajegheh


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2022 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
SNSamira Nakhaie
Samira Nakhaie
RYRostam Yazdani
Rostam Yazdani
MSMohammadreza Shakibi
Mohammadreza Shakibi
STSoheila Torabian
Soheila Torabian
SPSara Pezeshki
Sara Pezeshki
FSFaranak Salajegheh
Faranak Salajegheh

30 September 2024 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
ZGZohreh‐Al‐Sadat Ghoreshi
Zohreh‐Al‐Sadat Ghoreshi
JCJavad Charostad
Javad Charostad
NAnasir arefinia
nasir arefinia
MNMohsen Nakhaie
Mohsen Nakhaie
MRMohammad Rezaei Zadeh Rukerf
Mohammad Rezaei Zadeh Rukerf
FSFaranak Salajegheh
Faranak Salajegheh
The COVID‐19 pandemic has emerged as a major global health crisis. Vitamin D, a crucial fat‐soluble vitamin, has been recommended for COVID‐19 patients, though evidence of its effectiveness is inconsistent. This systematic literature review and meta‐analysis aimed to evaluate the impact of vitamin D supplementation on COVID‐19‐related outcomes. A comprehensive search was conducted across PubMed, Scopus, Web of Science, Embase, and Cochrane databases. Primary outcomes included mortality and hospital length of stay, while secondary outcomes encompassed C‐reactive protein (CRP), ferritin, D‐dimer, hemoglobin (Hb) concentrations, and lymphocyte, neutrophil, and platelet counts. Data analysis was performed using Stata™ Version 14. A total of 16 trials were analyzed. The meta‐analysis revealed that vitamin D supplementation significantly reduced hospital length of stay (mean difference = −1.16; 95% confidence interval [CI]: −2.23, −0.09; p = .033) with significant heterogeneity (I2 = 69.2%, p = .002). Subgroup analysis showed a more pronounced reduction in studies with vitamin D dosages ≤10 000 international units (IU) (mean difference = −1.27; 95% CI: −1.96, −0.57; p < .001) and in patients over 60 years old (mean difference = −1.84; 95% CI: −2.53, −1.14; p < .001). Additionally, vitamin D significantly reduced CRP concentrations in older adults (>60 years) (mean difference = −1.13; 95% CI: −2.07, −0.18; p = .019). No significant changes were found in ferritin, D‐dimer, Hb concentrations, or in lymphocyte, neutrophil, and platelet counts (p > .05). In conclusion, while vitamin D supplementation did not significantly affect most COVID‐19‐related biomarkers, however, it reduces the length of hospital stay.

28 November 2015 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
NBNadieh Baniasadi
Nadieh Baniasadi
FSFaranak Salajegheh
Faranak Salajegheh
APAbbas Pardakhty
Abbas Pardakhty
SSSeyed Mehdi Seyedmirzaee
Seyed Mehdi Seyedmirzaee
MHMohammad Mahdi Hayatbakhsh
Mohammad Mahdi Hayatbakhsh
MMMojgan Mohammadi
Mojgan Mohammadi
Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran - Hepatitis Monthly - - Kowsar

1 December 2024 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
AGAli Ghorbani
Ali Ghorbani
RKRoxana Kaveh
Roxana Kaveh
MRMohammad Rezaei Zadeh Rukerd
Mohammad Rezaei Zadeh Rukerd
HMHanieh Mirkamali
Hanieh Mirkamali
FAFatemeh Ahmadpour
Fatemeh Ahmadpour
FSFaranak Salajegheh
Faranak Salajegheh
Introduction: Chylopericardium, a rare condition involving the accumulation of chylous fluid in the pericardial cavity, arises due to lymphatic system disruption. It is frequently linked to trauma, malignancy, or cardiothoracic surgeries. Although primarily reported in pediatric cases, its occurrence in adults, particularly following coronary artery bypass graft (CABG), is rare. Case presentation: We present the case of a 62-year-old male who, one week after CABG, developed progressive dyspnea, weakness, and fatigue. Physical examination revealed signs of cardiac tamponade, and echocardiography confirmed severe pericardial effusion with right ventricular collapse. Pericardial fluid analysis demonstrated chylous fluid with elevated triglycerides and protein levels, diagnosing chylopericardium-induced cardiac tamponade. Despite surgical intervention, an emergency pericardiocentesis was performed to stabilize the patient, followed by a pericardial window, thoracic duct ligation, and aggressive management with total parenteral nutrition (TPN) and albumin; however, the patient's condition deteriorated, resulting in cardiac arrest and death. Discussion: Chylopericardium following cardiac surgery is a rare but serious complication. It typically arises from inadvertent injury to the thoracic duct during the procedure, exacerbated by increased postoperative venous pressure. Diagnosis hinges on pericardiocentesis, revealing milky fluid with high triglycerides and protein levels. While conservative treatment may suffice in minor cases, severe chylopericardium often necessitates surgical intervention. This case underscores the challenge of diagnosing this rare complication and the critical need for timely intervention. Conclusion: This case highlights the importance of early recognition and aggressive management of post-CABG chylopericardium. Rapid deterioration, despite prompt treatment, emphasizes the need for heightened clinical awareness to prevent fatal outcomes. Highlights:

1 January 2024 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
FSFaranak Salajegheh
Faranak Salajegheh
MRMohammad Rezaei Zadeh Rukerf
Mohammad Rezaei Zadeh Rukerf
MNMohsen Nakhaie
Mohsen Nakhaie
ZGZohreh-Al-Sadat Ghoreshi
Zohreh-Al-Sadat Ghoreshi
JCJavad Charostad
Javad Charostad
NAnasir arefinia
nasir arefinia
Salajegheh F, et al. Clin Exp Vaccine Res. 2024 Apr;13(2):83-90. https://doi.org/10.7774/cevr.2024.13.2.83

6 November 2024 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
ZGZohreh-Al-Sadat Ghoreshi
Zohreh-Al-Sadat Ghoreshi
JCJavad Charostad
Javad Charostad
NAnasir arefinia
nasir arefinia
MNMohsen Nakhaie
Mohsen Nakhaie
MRMohammad Rezaei Zadeh Rukerf
Mohammad Rezaei Zadeh Rukerf
FSFaranak Salajegheh
Faranak Salajegheh
: The COVID-19 pandemic has exerted a notable impact on worldwide health across diverse age groups. Although children and adolescents were initially considered less vulnerable, they have also shown susceptibility to the virus, emphasizing the importance of understanding associated risk factors. Epidemiological data reveal an increasing number of COVID-19 cases in this age group. The aim is to conduct a systematic assessment of the association between the level of vitamin D and COVID-19 infection in children and adolescents following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed across various databases up to October 7, 2023. Studies assessing laboratory-confirmed COVID-19 patients, the level of 25-hydroxyvitamin D in serum, and clinical outcomes were encompassed. Quality assessment was performed using the Newcastle–Ottawa Scale. Thirteen studies, conducted across six countries and involving 1,071 pediatric patients, were included. Vitamin D deficiency was prevalent among children and adolescents with COVID-19. Some studies suggested that vitamin D deficiency significantly increased the risk of COVID-19 infection and was linked to disease progression. Furthermore, deficiency in vitamin D demonstrated an association with increased levels of inflammatory markers, reduced lymphocyte counts, and heightened clinical symptoms, including fever and cough. Maintaining adequate vitamin D levels may be a crucial strategy for reducing COVID-19 severity and associated complications in children and adolescents. Nevertheless, there is a requirement for additional high-quality research to establish specific guidelines regarding vitamin D supplementation in this population amid the ongoing COVID-19 pandemic.